Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.
Martín García-Sancho A, Baile M, Rodríguez G, Dlouhy I, Sancho JM, Jarque I, González-Barca E, Salar A, Espeso M, Grande C, Bergua J, Montes-Moreno S, Redondo A, Enjuanes A, Campo E, López-Guillermo A, Caballero D. Martín García-Sancho A, et al. Among authors: salar a. Br J Haematol. 2023 Oct;203(2):202-211. doi: 10.1111/bjh.18989. Epub 2023 Jul 23. Br J Haematol. 2023. PMID: 37485564 Clinical Trial.
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.
López-Guillermo A, Cid J, Salar A, López A, Montalbán C, Castrillo JM, González M, Ribera JM, Brunet S, García-Conde J, Fernández de Sevilla A, Bosch F, Montserrat E. López-Guillermo A, et al. Among authors: salar a. Ann Oncol. 1998 Aug;9(8):849-55. doi: 10.1023/a:1008418727472. Ann Oncol. 1998. PMID: 9789607 Free article. Review.
Indolent course as presentation in t-prolymphocytic leukaemia.
Domingo-Domènech E, González-Barca E, Salar A, Clarós AD, Grañena A. Domingo-Domènech E, et al. Among authors: salar a. Br J Haematol. 1999 Jun;105(3):840. doi: 10.1046/j.1365-2141.1999.01485.x. Br J Haematol. 1999. PMID: 10354157 Free article. No abstract available.
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens.
Salar A, Sierra J, Gandarillas M, Caballero MD, Marín J, Lahuerta JJ, García-Conde J, Arranz R, León A, Zuazu J, García-Laraña J, López-Guillermo A, Sanz MA, Grañena A, García JC, Conde E; GEL/TAMO Spanish Cooperative Group. Salar A, et al. Bone Marrow Transplant. 2001 Feb;27(4):405-12. doi: 10.1038/sj.bmt.1702795. Bone Marrow Transplant. 2001. PMID: 11313670
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.
González-Barca E, Domingo-Domenech E, Capote FJ, Gómez-Codina J, Salar A, Bailen A, Ribera JM, López A, Briones J, Muñoz A, Encuentra M, de Sevilla AF; GEL/TAMO (Grupo Español de Linfomas); GELCAB (Grupo para el Estudio de los Linfomas Catalano-Balear); GOTEL (Grupo Oncológico para el Tratamiento y Estudio de los Linfomas). González-Barca E, et al. Among authors: salar a. Haematologica. 2007 Nov;92(11):1489-94. doi: 10.3324/haematol.11360. Haematologica. 2007. PMID: 18024397 Free article. Clinical Trial.
193 results